| Bioactivity | CDK9-IN-1 is a novel, selective CDK9 inhibitor for the treatment of HIV infection, with an IC50 of 39 nM for CDK9/CycT1, extracted from reference, compound 87. | ||||||||||||
| Invitro | CDK9-IN-1 is a potent CDK9 inhibitor that shows high activity against HIV-1 replication[1]. | ||||||||||||
| Name | CDK9-IN-1 | ||||||||||||
| CAS | 1415559-43-1 | ||||||||||||
| Formula | C26H21N5O4S | ||||||||||||
| Molar Mass | 499.54 | ||||||||||||
| Appearance | Solid | ||||||||||||
| Transport | Room temperature in continental US; may vary elsewhere. | ||||||||||||
| Storage |
|
||||||||||||
| Reference | [1]. Nemeth G, et al. Novel, selective CDK9 inhibitors for the treatment of HIV infection. Curr Med Chem. 2011;18(3):342-358. |